[1] |
Fraietta R, Zylberstejn DS, Esteves SC. Hypogonadotropic hypogonadism revisited[J]. Clinics (Sao Paulo), 2013, 68(Suppl 1): 81–88.
|
[2] |
Pitteloud N, Dwyer A. Hormonal control of spermatogenesis in men: therapeutic aspects in hypogonadotropic hypogonadism[J]. Ann Endocrinol (Paris), 2014, 75(2): 98–100.
|
[3] |
Collins JS, Marshall JC, McCartney CR. Differential sleep-wake sensitivity of gonadotropin-releasing hormone secretion to progesterone inhibition in early pubertal girls[J]. Neuroendocrinology, 2012, 96(3): 222–227.
|
[4] |
都春风,杨国庆,母义明,等.男性特发性低促性腺激素型性腺功能减退症87例临床分析[J]. 中国实用内科杂志,2007, 27(23): 1839–1841.
|
[5] |
Delemarre-van de Waal HA. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects[J]. Eur J Endocrinol, 2004, 151(Suppl 3): U89–U94.
|
[6] |
孙首悦,王卫庆,蒋怡然,等.微量泵脉冲输注戈那瑞林治疗特发性低促性腺激素性性腺功能减退症[J].中华内分泌代谢杂志,2011, 27(8):654–658.
|
[7] |
Pitteloud N, Hayes FJ, Dwyer A, et al. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism[J]. J Clin Endocrinol Metab, 2002, 87(9): 4128–4136.
|
[8] |
Christin-Maitre S, De Crécy M, Groupe Français des pompes à GnRH. Pregnancy outcomes following pulsatile GnRH treatment: results of a large multicenter retrospective study[J]. J Gynecol Obstet Biol Reprod (Paris), 2007, 36(1): 8–12.
|
[9] |
Abel BS, Shaw ND, Brown JM, et al. Responsiveness to a physiological regimen of GnRH therapy and relation to genotype in women with isolated hypogonadotropic hypogonadism[J]. J Clin Endocrinol Metab, 2013, 98(2): E206–E216.
|
[10] |
Gronier H, Peigné M, Catteau-Jonard S, et al. Ovulation induction by pulsatile GnRH therapy in 2014: literature review and synthesis of current practice[J]. Gynecol Obstet Fertil, 2014, 42(10): 732–740.
|
[11] |
孙首悦,贾慧英,朱巍,等.促性腺激素释放激素皮下微量脉冲输注治疗中枢性继发性闭经一例临床研究[J].中华内分泌杂志,2014,30(3): 197–200.
|
[12] |
Graña-Barcia M, Liz-Lestón J, Lado-Abeal J. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study[J]. Fertil Steril, 2005, 83(5): 1466–1472.
|
[13] |
Gill S, Taylor AE, Martin KA, et al. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome[J]. J Clin Endocrinol Metab, 2001, 86(6): 2428–2436.
|
[14] |
Dubourdieu S, Fréour T, Dessolle L, et al. Prospective, randomized comparison between pulsatile GnRH therapy and combined gonadotropin (FSH+LH) treatment for ovulation induction in women with hypothalamic amenorrhea and underlying polycystic ovary syndrome[J].Eur J Obstet Gynecol Reprod Biol, 2013, 168(1): 45–48.
|
[15] |
Bayram N, van Wely M, van der Veen F. Pulsatile gonadotrophin releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome[J]. Cochrane Database Syst Rev, 2004, 1: CD000412.
|
[16] |
李卓莉,郝敏,赵卫红.腹腔镜手术联合促性腺激素释放激素激动剂治疗深部浸润型子宫内膜异位症的临床疗效分析[J/CD].中华妇幼临床医学杂志:电子版,2014,10(2): 189–198.
|
[17] |
Hughes VA, Boepple PA, Crowley WF Jr, et al. Interplay between dose and frequency of GnRH administration in determining pituitary gonadotropin responsiveness[J]. Neuroendocrinology, 2008, 87(3): 142–150.
|
[18] |
Martin KA, Santoro N, Hall JE, et al. Management of ovulatory disorders with pulsatile gonadotropin-releasing hormone[J]. Clin Endocrinol Metab, 1990, 71(5): 1081A–1081G.
|
[19] |
Seminara SB, Beranova M, Oliveira LM, et al. Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations[J]. J Clin Endocrinol Metab, 2000, 85(2): 556–562.
|
[20] |
King TF, Hayes FJ. Long-term outcome of idiopathic hypogonadotropic hypogonadism[J]. Curr Opin Endocrinol Diabetes Obes, 2012, 19(3): 204–210.
|
[21] |
Mao JF, Xu HL, Duan J, et al. Reversal of idiopathic hypogonadotropic hypogonadism: a cohort study in Chinese patients[J]. Asian J Androl, 2015, 17(3): 497–502.
|